Adolescent self-harm with and without suicidality: cross-sectional and longitudinal analyses of a Swedish regional register.


Journal

Journal of child psychology and psychiatry, and allied disciplines
ISSN: 1469-7610
Titre abrégé: J Child Psychol Psychiatry
Pays: England
ID NLM: 0375361

Informations de publication

Date de publication:
03 2019
Historique:
accepted: 16 07 2018
pubmed: 13 9 2018
medline: 23 7 2020
entrez: 13 9 2018
Statut: ppublish

Résumé

Self-harm is common and there is a need for studies that investigate the relevance of this behavior in clinical samples to inform risk assessment and treatment. The objectives in the current studies were to compare clinical and psychosocial correlates and subsequent adverse outcomes in youth who present to child and adolescent mental health services (CAMHS) with self-harm only (SH), self-harm with suicidality (SH+SU), with those without any indication of SH or SH+SU. We conducted a case-control study and a longitudinal cohort study using data from a regional clinical care register, and Swedish national registers. The case-control study included all patients (5-17 years) between 2011 and 2015 (N = 25,161). SH and SH+SU cases were compared with controls (patients without SH) regarding a range of correlates. The longitudinal study included former CAMHS patients (N = 6,120) who were followed for a median time of 2.8 years after termination of CAMHS contact regarding outcomes such as clinical care consumption, social welfare recipiency, and crime conviction. In the case-control study, both the SH and SH+SU groups received more clinical care, had lower global functioning, and higher odds of having mental disorders compared to controls. In most comparisons, the SH+SU group had more problems than the SH group. In the longitudinal study, the same pattern emerged for most outcomes; for example, the adjusted hazard ratio for recurrent care due to self-harm was 23.1 (95% confidence interval [CI], 17.0-31.4) in the SH+SU group compared to 3.9 (95% CI, 2.3-6.7) in the SH group. Adolescent patients presenting with self-harm have higher risks for adverse outcomes than patients without self-harm. Suicidality in addition to self-harm is associated with more severe outcomes, importantly recurrent episodes of care for self-harm.

Sections du résumé

BACKGROUND
Self-harm is common and there is a need for studies that investigate the relevance of this behavior in clinical samples to inform risk assessment and treatment. The objectives in the current studies were to compare clinical and psychosocial correlates and subsequent adverse outcomes in youth who present to child and adolescent mental health services (CAMHS) with self-harm only (SH), self-harm with suicidality (SH+SU), with those without any indication of SH or SH+SU.
METHODS
We conducted a case-control study and a longitudinal cohort study using data from a regional clinical care register, and Swedish national registers. The case-control study included all patients (5-17 years) between 2011 and 2015 (N = 25,161). SH and SH+SU cases were compared with controls (patients without SH) regarding a range of correlates. The longitudinal study included former CAMHS patients (N = 6,120) who were followed for a median time of 2.8 years after termination of CAMHS contact regarding outcomes such as clinical care consumption, social welfare recipiency, and crime conviction.
RESULTS
In the case-control study, both the SH and SH+SU groups received more clinical care, had lower global functioning, and higher odds of having mental disorders compared to controls. In most comparisons, the SH+SU group had more problems than the SH group. In the longitudinal study, the same pattern emerged for most outcomes; for example, the adjusted hazard ratio for recurrent care due to self-harm was 23.1 (95% confidence interval [CI], 17.0-31.4) in the SH+SU group compared to 3.9 (95% CI, 2.3-6.7) in the SH group.
CONCLUSIONS
Adolescent patients presenting with self-harm have higher risks for adverse outcomes than patients without self-harm. Suicidality in addition to self-harm is associated with more severe outcomes, importantly recurrent episodes of care for self-harm.

Identifiants

pubmed: 30207392
doi: 10.1111/jcpp.12967
pmc: PMC7379534
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

295-304

Informations de copyright

© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.

Références

Br J Clin Pharmacol. 2013 Jul;76(1):145-57
pubmed: 23216533
J Psychiatr Res. 2017 Jan;84:105-112
pubmed: 27716512
J Affect Disord. 2014 Oct;168:407-14
pubmed: 25108277
J Affect Disord. 2016 Jun;197:231-8
pubmed: 26995466
Br J Psychiatry. 2013 May;202(5):326-8
pubmed: 23637107
Psychiatry Res. 2015 Aug 30;228(3):454-61
pubmed: 26144578
Psychiatry Res. 2010 May 15;177(1-2):206-10
pubmed: 20334931
Arch Gen Psychiatry. 1983 Nov;40(11):1228-31
pubmed: 6639293
Acta Psychiatr Scand. 2015 Jan;131(1):61-8
pubmed: 24954250
Suicide Life Threat Behav. 2009 Oct;39(5):518-37
pubmed: 19929152
Cochrane Database Syst Rev. 2015 Dec 21;(12):CD012013
pubmed: 26688129
J Am Acad Child Adolesc Psychiatry. 2013 Dec;52(12):1260-71
pubmed: 24290459
BMJ. 2014 Oct 21;349:g5954
pubmed: 25335825
Clin Psychol Rev. 2012 Aug;32(6):482-95
pubmed: 22717336
J Child Psychol Psychiatry. 2003 Nov;44(8):1191-8
pubmed: 14626459
Arch Suicide Res. 2009;13(2):105-22
pubmed: 19363748
Lancet Psychiatry. 2018 Jan;5(1):51-64
pubmed: 29196062
Annu Rev Clin Psychol. 2010;6:339-63
pubmed: 20192787
JAMA Psychiatry. 2017 Jun 1;74(6):615-621
pubmed: 28384711
J Abnorm Psychol. 2009 Nov;118(4):816-27
pubmed: 19899851
Child Adolesc Psychiatry Ment Health. 2012 Mar 30;6:11
pubmed: 22463065
Psychol Med. 2016 Dec;46(16):3397-3405
pubmed: 27644850
Ann Fam Med. 2017 May;15(3):246-254
pubmed: 28483890
Arch Pediatr Adolesc Med. 2007 Jul;161(7):641-9
pubmed: 17606826

Auteurs

Johan Bjureberg (J)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Anna Ohlis (A)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.

Brjánn Ljótsson (B)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Brian M D'Onofrio (BM)

Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA.

Erik Hedman-Lagerlöf (E)

Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Jussi Jokinen (J)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Department of Clinical Sciences, Umeå University, Umeå, Sweden.

Hanna Sahlin (H)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Paul Lichtenstein (P)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Martin Cederlöf (M)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Clara Hellner (C)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH